Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Aug. 10, 2018. Ted Davis.

Executive Summary

Active Implants is ramping up for a 2019 commercial launch of its NUsurface polycarbonate-urethane meniscus implant as it continues clinical trials in the US. The firm hopes to earn US approval for the device by the end of 2020. See what Active Implants CEO Ted Davis said about it here.

"We've been really focused on collecting data to get to more global approvals, [and] our focus for the last several years has been on the US trial and all the efforts there. Beginning in 2019 our goal is to do some limited commercial release, working with the current sites where we did our clinical work in Europe, before coming to the US." –Ted Davis, CEO, Active Implants LLC

Click here for a free trial of Medtech Insight
 
Advertisement

Related Content

Active Implants Plans 2019 Commercial Release For NUsurface Meniscus Implant

Topics

Advertisement
UsernamePublicRestriction

Register

MT123108

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel